Alterity Therapeutics
ATHE
8 hedge funds and large institutions have $144K invested in Alterity Therapeutics in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
14% more funds holding
Funds holding: 7 → 8 (+1)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
12% less capital invested
Capital invested by funds: $163K → $144K (-$19.6K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAS
Coppell Advisory Solutions
Coppell,
Texas
|
+$391 |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$352 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.94K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $128K | -$1.94K | -700 | -1% |
|
|
TLCM
2
Twin Lakes Capital Management
Redwood Shores,
California
| $14.7K | – | – | – |
|
|
PCA
3
Providence Capital Advisors
Charlotte,
North Carolina
| $496 | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $315 | +$352 | +127 | New |
|
5
Osaic Holdings
Scottsdale,
Arizona
| $199 | – | – | – |
|
|
SWM
6
Sugarloaf Wealth Management
Duluth,
Georgia
| $82 | – | – | – |
|
|
CAS
7
Coppell Advisory Solutions
Coppell,
Texas
| $52 | +$391 | +141 | +1,763% |
|
|
SPIA
8
Steward Partners Investment Advisory
New York
| $15 | – | – | – |
|
ATHE Hedge Fund Activity: Q3 2023 in Review
8 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q3 2023, worth a combined $144K — down 12% from $163K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ATHE positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Coppell Advisory Solutions, adding an estimated $391. The largest seller was Morgan Stanley, cutting an estimated $1.94K.
- 8 institutional investors held Alterity Therapeutics (ATHE) as of Q3 2023, up from 7 in Q2 2023.
- Funds reported $144K of Alterity Therapeutics stock for Q3 2023, down 12% quarter-over-quarter.
- 1 fund opened new Alterity Therapeutics positions in Q3 2023 and 0 closed out, a net change of +1 holder.
- The largest Alterity Therapeutics buyer in Q3 2023 was Coppell Advisory Solutions, an estimated $391 added.
- The largest Alterity Therapeutics seller in Q3 2023 was Morgan Stanley, an estimated $1.94K sold.
Based on aggregated 13F filings for Q3 2023.